References
- 1. Serban V, Sima A, Popa S. Endogenous hypoglycemia. Metabolic diseases. Brumar, 2010: 189-199.
- 2. Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335.10.21037/atm.2018.07.32
- 3. Saxon DR, McDermott MT, Michels AW. Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2016;101(5):1931-1934.10.1210/jc.2016-1097
- 4. Uchigata Y, Hirata Y. Insulin autoimmune syndrome (Hirata Disease). In Immunoendocrinology: Scientific and Clinical Aspects. Totowa, NJ: Humana Press, 2011:343-67.10.1007/978-1-60327-478-4_21
- 5. Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol. 2000;61(2):154-157.10.1016/S0198-8859(99)00144-5
- 6. Advani A. Positioning time in range in diabetes management. Diabetologia. 2020;63(2):242-252.10.1007/s00125-019-05027-031701199
- 7. Ismail AA. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Lab Med. 2016;54(11):1715-1724.10.1515/cclm-2015-125527071154
- 8. Wong SL, Priestman A, Holmes DT. Recurrent hypoglycemia from insulin autoimmune syndrome. J Gen Intern Med. 2014;29(1):250-254.10.1007/s11606-013-2588-9388995923979685
- 9. Cappellani D, Macchia E, Falorni A, Marchetti P. Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description. Diabetes Metab Syndr Obes. 2020;13:963-978.10.2147/DMSO.S219438713666532308449
- 10. Eguchi Y, Uchigata Y, Yao K, Yokoyama H, Hirata Y, Omori Y. Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata’s disease). Autoimmunity.1994;19(4):279-284.10.3109/089169394090713547578855
- 11. Ismail AA. The double whammy of endogenous insulin antibodies in non-diabetic subjects. Clin Chem Lab Med. 2008;46(2):153-6.10.1515/CCLM.2008.03118324904
- 12. Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009;83(1):e19-e20.10.1016/j.diabres.2008.10.01519070385
- 13. Censi S, Albergoni M, Gallo N, Plebani M, Boscaro M, Betterle C. Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature. Clinical Chem Lab Med.2018;56(6):889-895.10.1515/cclm-2017-039228917079
- 14. Philippon M, Sejil S, Mugnier M, et al. Use of the continuous glucose monitoring system to treat insulin autoimmune syndrome: quantification of glucose excursions and evaluation of treatment efficacy. Diabet Med. 2014;31(7):e20-e24.10.1111/dme.1241825077287